GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) - NEONATAL SCREENING - ANVISA Registration 81541770003
Access comprehensive regulatory information for GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81541770003 and manufactured by manufacturer not specified. The registration is held by SUPER DIAGNOSTICA PRODS HOSP LTDA EPP with validity until Jul 21, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including WALLAC OY, INTERNACIONAL CIENTรFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
81541770003
25351022642202577
27437056000164
Company Information
Dates and Status
Jul 21, 2025
21/07/2035
09/18/2025 19:00:01
DESIDROGENASE GLICOSE-6-FOSFATO (G6PD) - TRIAGEM NEONATAL
GSP NEONATAL G6PD KIT
Not specified
10298910130
Jun 08, 2015
DESIDROGENASE GLICOSE-6-FOSFATO (G6PD) - TRIAGEM NEONATAL
GSP NEONATAL G6PD KIT
WALLAC OY
10298910130
Jun 08, 2015
DESIDROGENASE GLICOSE-6-FOSFATO (G6PD) - TRIAGEM NEONATAL
Kit NeoLISA G6PD
INTERNACIONAL CIENTรFICA LTDA
80173700008
Nov 30, 2009
DESIDROGENASE GLICOSE-6-FOSFATO (G6PD) - TRIAGEM NEONATAL
G6PD NEONATAL
WALLAC OY
10298910073
Mar 07, 2005
DESIDROGENASE GLICOSE-6-FOSFATO (G6PD) - TRIAGEM NEONATAL
G6PD NEONATAL
Not specified
10298910073
Mar 07, 2005

